Support for COVID-19 test development
Actim offers a serological antibody detection ELISA test for detecting recent COVID-19 infection. A highly reliable Actim ELISA SARS-CoV-2 IgG test gives quantitative results in less than two hours with outstanding specificity (98%) and sensitivity (96%).
The test provides R&D and research laboratories an accurate and efficient comparison method for product verifications.
Actim ELISA SARS-CoV-2 IgG test will be one the most reliable tests on the market:
| Sensitivity |
Specificity | PPV | NPV | Accuracy |
| 96% | 98% | 87% | 99% | 98% |
More detailed information on Actim ELISA SARS-CoV-2 IgG test can be found here. If you wish to hear more, please contact our Actim Sales Team.
CE-mark of the Actim ELISA SARS-CoV-2 IgG test is expected to be completed in early December 2020, but samples for evaluation purposes are available now.